A Retrospective Analysis of the Efficacy and Safety of Imatinib for Advanced Gastrointestinal Stromal Tumor in Elderly Patients
Imatinib is an effective treatment for advanced GIST in elderly patients. However, elderly patients were associated with poorer efficacy and a Higher incidence of toxicities due to imatinib compared with non-elderly patients.
Authors
- Atsuo Takashima
- Kengo Nagashima (ORCID: https://orcid.org/0000-0003-4529-9045)
- Takahito Awatsu (ORCID: https://orcid.org/0009-0004-9512-087X)
- Hidekazu Hirano (ORCID: https://orcid.org/0000-0003-1343-1419)
- Akihito Nagahara (ORCID: https://orcid.org/0000-0001-5979-4384)
- Natsuko Okita (ORCID: https://orcid.org/0000-0002-3990-5048)
- Ken Kato (ORCID: https://orcid.org/0000-0001-6993-5152)
- Hirokazu Shoji
- Toshiharu Hirose (ORCID: https://orcid.org/0009-0002-3623-6691)
Institutions
- Juntendo University (JP)
- Keio University Hospital (JP)
- National Cancer Center Hospital East (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1002/cam4.71338
- Primary Topic
- Gastrointestinal Tumor Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00